Quality of Life and Sexuality in Patients Treated With Radical Radiotherapy for Prostate Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Quality of Life
- Sponsor
- Istituto Clinico Humanitas
- Locations
- 1
- Primary Endpoint
- Quality of life measurement
- Status
- Withdrawn
- Last Updated
- 6 years ago
Overview
Brief Summary
The trial is to describe quality of life in patients affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation.
Detailed Description
This trial is to describe quality of life and sexuality in patients with prostate cancer treated with exclusive radiotherapy. Descriptive analysis of baseline characteristics will be performed by using appropriate summary measures for continous and categorical data. Analysis of variation over time of FACT scores will be conducted by means of ANOVA analysis for repeated measures.
Investigators
Michele Tedeschi
Medical Doctor
Istituto Clinico Humanitas
Eligibility Criteria
Inclusion Criteria
- •Age 18-75 years.
- •Histologically-proven of prostate cancer
- •Indication to radical radiotherapy on prostate/ prostate + seminal vesicles / prostate + seminal vesicles + pelvic lymph nodes
- •Informed consent
Exclusion Criteria
- •Other coexisting malignancies, uncontrolled intercurrent illness, active infectious processes, and exudative, bloody, or cytologically malignant effusions excluded patients from the trial.
- •Previous surgery for prostate cancer, severe cardiac or vascular pathology
- •Other major surgery in the preceding year or currently undergoing psychiatric care or psychological counseling.
Outcomes
Primary Outcomes
Quality of life measurement
Time Frame: 2.5 years
Evaluation of the quality of life with FACT-P test in patient affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation